Cargando…
Pharmacogenomic insights into treatment and management of statin-induced myopathy
Although statins are generally well tolerated, the most common adverse drug reaction from statin therapy is myopathy. This article reviews the current pharmacogenomic knowledge of statin-induced myopathy. Furthermore, we will discuss the importance of recent pharmacogenetic advances for the treatmen...
Autores principales: | Peters, Bas JM, Klungel, Olaf H, Visseren, Frank L, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808736/ https://www.ncbi.nlm.nih.gov/pubmed/20090898 http://dx.doi.org/10.1186/gm120 |
Ejemplares similares
-
Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010) -
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing
por: Floyd, James S., et al.
Publicado: (2019) -
Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine
por: Maagdenberg, Hedy, et al.
Publicado: (2016) -
Management of statin myopathy
por: Finsterer, Josef, et al.
Publicado: (2017) -
Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009)